zoledronic acid has been researched along with Musculoskeletal Pain in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, AB; Conwell, LS; Jeffery, TC | 1 |
| Liao, Z; Qu, C; Ye, J; Ye, X; Zhan, Q; Zhao, W; Zheng, X | 1 |
| Blanch, J; Boers, M; Brandi, ML; Cetnarskyj, R; Chandra, R; Charnock, K; Cronin, O; Crowley, RK; Del Pino-Montes, J; Devogelaer, JP; Di Stefano, M; Duncan, EL; Durnez, A; Forsyth, L; Fraser, WD; Gennari, L; Gilchrist, NL; Goodman, K; Guañabens, N; Hampson, G; Ho, S; Horne, A; Isaia, G; Keerie, C; Kotowicz, MA; Lewis, SC; Major, G; McKenna, MJ; Murray, GD; Nicholson, GC; Nuti, R; Porteous, M; Ralston, SH; Ranganath, LR; Russell, RGG; Seibel, MJ; Selby, PL; Tobias, JH; Walker, A; Walsh, JP; Wilkinson, D; Young-Min, S | 1 |
| Bilodeau, C; Boitor, M; Carrier, JI; Ferland, CE; Le May, S; Ngheim, T; Rauch, F; Tsimicalis, A | 1 |
| Asha, HS; Cherian, KE; Paul, TV; Rajan, R | 1 |
| Makhloufi, H; Nezzar, A; Slimani, S | 1 |
| Klatte, T; Kratzik, C; Remzi, M; Sinzinger, H; Waldert, M | 1 |
| Atteritano, M; Basile, G; Catalano, A; Cucinotta, D; Lasco, A; Morabito, N | 1 |
| Barney, RB; Biskupiak, JE; Brandt, P; Gaffney, DK; Namjoshi, M; Nickman, NA; Young, J | 1 |
| Huang, B; Li, CL; Liang, R; Pan, LH; Qian, W; Zheng, WW; Zhong, JH; Zhu, M | 1 |
2 review(s) available for zoledronic acid and Musculoskeletal Pain
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in people with cystic fibrosis.
Topics: Adult; Alendronate; Bone Density Conservation Agents; Child; Cystic Fibrosis; Diphosphonates; Female; Fractures, Bone; Humans; Musculoskeletal Pain; Osteoporosis; Pamidronate; Quality of Life; Randomized Controlled Trials as Topic; Spinal Fractures; Zoledronic Acid | 2023 |
Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Musculoskeletal Pain; Pain Measurement; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid | 2013 |
2 trial(s) available for zoledronic acid and Musculoskeletal Pain
| Article | Year |
|---|---|
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
Topics: Adult; Anxiety; Bone Density Conservation Agents; Depression; Genetic Testing; Humans; Musculoskeletal Pain; Mutation; Osteitis Deformans; Quality of Life; Radionuclide Imaging; Randomized Controlled Trials as Topic; Sequestosome-1 Protein; Zoledronic Acid | 2019 |
Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Middle Aged; Musculoskeletal Pain; Osteoporosis, Postmenopausal; Pilot Projects; Prospective Studies; Vitamin D; Vitamins; Zoledronic Acid | 2012 |
6 other study(ies) available for zoledronic acid and Musculoskeletal Pain
| Article | Year |
|---|---|
Prediction of musculoskeletal pain after the first intravenous zoledronic acid injection in patients with primary osteoporosis: development and evaluation of a new nomogram.
Topics: Adolescent; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Humans; Musculoskeletal Pain; Nomograms; Osteoporosis; Vitamin D; Zoledronic Acid | 2023 |
Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle.
Topics: Adolescent; Bone Density Conservation Agents; Child; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Musculoskeletal Pain; Osteogenesis Imperfecta; Pain Measurement; Pain Perception; Parents; Pilot Projects; Prospective Studies; Quality of Life; Self Report; Treatment Outcome; Young Adult; Zoledronic Acid | 2018 |
McCune Albright syndrome: an endocrine medley.
Topics: Adenoma; Bone Density Conservation Agents; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Female; Fibrous Dysplasia, Polyostotic; Humans; Hyperthyroidism; Leg; Musculoskeletal Pain; Pituitary Neoplasms; Rare Diseases; Young Adult; Zoledronic Acid | 2019 |
Successful treatment of pain in melorheostosis with zoledronate, with improvement on bone scintigraphy.
Topics: Adult; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Melorheostosis; Musculoskeletal Pain; Pain Measurement; Radionuclide Imaging; Treatment Outcome; Zoledronic Acid | 2013 |
Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer?
Topics: Aged; Analgesics, Non-Narcotic; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Interactions; Humans; Imidazoles; Male; Middle Aged; Musculoskeletal Pain; Orchiectomy; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Zoledronic Acid | 2012 |
Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Diphosphonates; Disease Progression; Female; Fractures, Spontaneous; Humans; Imidazoles; Middle Aged; Musculoskeletal Pain; Palliative Care; Retrospective Studies; Treatment Outcome; Young Adult; Zoledronic Acid | 2013 |